COVID-19 sarilumab trial terminated after treatment shows no benefit

In the multi-centre phase 3 trial, sarilumab failed to achieve the primary and key secondary endpoints.
In the multi-centre phase 3 trial, sarilumab failed to achieve the primary and key secondary endpoints.